InsiderClue

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
Companies 0/25
Result 23,393 decisions over 12 months
Reset filters
Direction ?
Both36,704 Bought13,311 Sold23,393
Sort by ?
Most recent Largest amount Share of holding
Window ?
1 mo 12 mo
Plan ?
Any Discretionary Scheduled (10b5-1) Not stated
Minimum amount ?
Any $100K $1M $10M $100M $500M
Share of their own holding ?
What the chief executive holds ?
Direction: Sold Plan: Discretionary
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
ECAT BlackRock ESG Capital Allocation Term Trust
22 Oct 2025
Saba Capital Management, L.P.
10% owner indirect
Sold at will
28,112
$456.82K
0.1%
NPWR Net Power Inc.
22 Oct 2025
NPEH, LLC
10% owner
Sold at will
89,000
$294.33K
2.6%
NPWR Net Power Inc.
22 Oct 2025
8 Rivers Capital, LLC
10% owner indirect
Sold at will
89,000
$294.33K
2.6%
DGX Quest Diagnostics
22 Oct 2025
PFEIFFER GARY M
Director
Sold at will
1,482
$270.32K
4.8%
GALT GALECTIN THERAPEUTICS INC
22 Oct 2025
10X Fund, L.P.
10% owner
Sold at will 2×
50,000
$246.80K
0.8%
AIFF FIREFLY NEUROSCIENCE, INC.
22 Oct 2025
Windsor Private Capital LP
10% owner indirect
Sold at will
78,031
$161.73K
5.9%
ONMD OneMedNet Corp
22 Oct 2025
Green Aaron
Chief Executive Officer
Sold at will
64,767
$144.72K
3.4%
ODC Oil-Dri Corp of America
22 Oct 2025
Scheland Laura G
VP & GM of Consumer Products
Sold at will
850
$51.26K
2.1%
IMVT Immunovant, Inc.
22 Oct 2025
Geffner Michael
Chief Medical Officer
Sold at will
2,595
$49.38K
1.2%
IMVT Immunovant, Inc.
22 Oct 2025
Stout Jay S
Chief Technology Officer
Sold at will
2,520
$47.96K
1.2%
KALA KALA BIO, Inc.
22 Oct 2025
Bazemore Todd
Director
Sold at will
47,768
$39.65K
57.1%
SCWO 374Water Inc.
22 Oct 2025
Nagar Yaacov
10% owner
Sold at will 2×
93,791
$39.48K
0.3%
KALA KALA BIO, Inc.
22 Oct 2025
Brazzell Romulus K
SEE REMARKS
Sold at will
46,748
$38.80K
56.5%
KALA KALA BIO, Inc.
22 Oct 2025
Reumuth Mary
CHIEF FINANCIAL OFFICER
Sold at will
32,230
$26.75K
51.9%
AFB ALLIANCEBERNSTEIN NATIONAL MUNICIPAL INCOME FUND
22 Oct 2025
Saba Capital Management, L.P.
10% owner indirect
Sold at will
1,955
$21.56K
0.1%
KALA KALA BIO, Inc.
22 Oct 2025
Kharabi Darius
CHIEF BUSINESS OFFICER
Sold at will
20,806
$17.27K
33.3%
ODYS Odysight.ai Inc.
22 Oct 2025
Y.D. More Investments Ltd
10% owner indirect
Sold at will
2,800
$9.46K
0.5%
UNTY UNITY BANCORP INC /NJ/
22 Oct 2025
Donovan James Joseph
Chief Lending Officer/FSVP
Sold at will
167
$8.07K
100%
MLSS MILESTONE SCIENTIFIC INC.
22 Oct 2025
BP4 S.r.l.
10% owner
Sold at will
14,427
$6.49K
0.2%
CD Chaince Digital Holdings Inc.
22 Oct 2025
Daye Wilfred ZhongKei
CSO
Sold at will
300
$2.86K
0.8%
AVAH Aveanna Healthcare Holdings, Inc.
21 Oct 2025
VIGANO PAUL R
10% owner indirect
Sold at will 3×
10,000,000
$90.00M
96.3%
AVAH Aveanna Healthcare Holdings, Inc.
21 Oct 2025
WILLIAMS ROBERT M JR
10% owner indirect
Sold at will 3×
10,000,000
$90.00M
96.3%
AVAH Aveanna Healthcare Holdings, Inc.
21 Oct 2025
J.H. Whitney Equity Partners VII, LLC
10% owner indirect
Sold at will
8,346,059
$75.11M
28.9%
RANI Rani Therapeutics Holdings, Inc.
21 Oct 2025
South Cone Investments Limited Partnership
10% owner indirect
Sold at will
4,000,000
$11.07M
62.7%
ORCL Oracle Corporation
21 Oct 2025
Magouyrk Clayton M.
Chief Executive Officer
Sold at will
40,000
$11.07M
20.6%
DAL Delta Air Lines
21 Oct 2025
Laughter John E
EVP & Chief of Operations
Sold at will
23,323
$1.45M
22.3%
ORCL Oracle Corporation
21 Oct 2025
Smith Maria
EVP, Chief Accounting Officer
Sold at will
5,000
$1.40M
8.8%
VOR Vor Biopharma Inc.
21 Oct 2025
RA CAPITAL MANAGEMENT, L.P.
Director indirect
Sold at will
25,027
$703.51K
1.8%
NPWR Net Power Inc.
21 Oct 2025
NPEH, LLC
10% owner
Sold at will
189,300
$668.36K
5.3%
NPWR Net Power Inc.
21 Oct 2025
8 Rivers Capital, LLC
10% owner indirect
Sold at will
189,300
$668.36K
5.3%
CGNX COGNEX CORP
21 Oct 2025
Willett Robert
Director
Sold at will
6,704
$331.89K
100%
BGMS Bio Green Med Solution, Inc.
21 Oct 2025
FITTERS Diversified Berhad
10% owner
Sold at will
92,352
$277.52K
24.9%
SNX TD SYNNEX CORP
21 Oct 2025
Dhanji Alim
Chief Human Resources Officer
Sold at will 6×
1,762
$272.32K
11.6%
EPAM EPAM Systems, Inc.
21 Oct 2025
Yezhkov Sergey
SVP/Co-Head of Global Business
Sold at will
1,511
$227.06K
91.2%
SCWO 374Water Inc.
21 Oct 2025
Nagar Yaacov
10% owner
Sold at will
284,394
$119.56K
0.9%
WRAP WRAP TECHNOLOGIES, INC.
21 Oct 2025
NORRIS ELWOOD G
10% owner
Sold at will
25,000
$67.36K
5.1%
ALOY REALLOYS INC.
21 Oct 2025
Reid Charles Keller
Director
Sold at will
5,000
$46.18K
23.5%
ALLO Allogene Therapeutics, Inc.
21 Oct 2025
Parker Geoffrey M.
CHIEF FINANCIAL OFFICER
Sold at will
36,744
$46.17K
2.8%
AIFF FIREFLY NEUROSCIENCE, INC.
21 Oct 2025
Windsor Private Capital LP
10% owner indirect
Sold at will
19,222
$46.14K
1.4%
SGA SAGA COMMUNICATIONS INC
21 Oct 2025
Edward K. Christian Trust
10% owner
Sold at will
1,669
$20.86K
0.2%
MLSS MILESTONE SCIENTIFIC INC.
21 Oct 2025
BP4 S.r.l.
10% owner
Sold at will
40,000
$17.59K
0.4%
FNGR FingerMotion, Inc.
21 Oct 2025
Leong Yew Poh
Director
Sold at will
9,997
$13.50K
5.3%
CD Chaince Digital Holdings Inc.
21 Oct 2025
Daye Wilfred ZhongKei
CSO
Sold at will
1,000
$12.96K
2.7%
VOR Vor Biopharma Inc.
21 Oct 2025
Reprogrammed Interchange LLC
10% owner
Sold at will
200
$6.02K
0.0%
BLK BlackRock
20 Oct 2025
Lord Rachel
Senior Managing Director
Sold at will 9×
12,000
$13.98M
62.5%
USB U.S. Bancorp
20 Oct 2025
CECERE ANDREW
Director
Sold at will
140,445
$6.51M
9.4%
CRWV CoreWeave, Inc.
20 Oct 2025
Magnetar Financial LLC
10% owner indirect
Sold at will 25×
44,181
$6.04M
12.3%
MTSI MACOM Technology Solutions Holdings, Inc.
20 Oct 2025
OCAMPO SUSAN
10% owner indirect
Sold at will
36,762
$5.18M
1.3%
RANI Rani Therapeutics Holdings, Inc.
20 Oct 2025
South Cone Investments Limited Partnership
10% owner indirect
Sold at will
1,923,000
$4.64M
23.2%
VOR Vor Biopharma Inc.
20 Oct 2025
RA CAPITAL MANAGEMENT, L.P.
Director indirect
Sold at will 4×
92,023
$2.73M
100%
Showing 22,901–22,950 of 23,393. ← Newer Page 459 of 468 Older →